Sale!

Ovaphil L

Original price was: ₹1,499.00.Current price is: ₹999.00.

& Free Shipping

Letrozole 2.5 mg, a type of aromatase inhibitor, serves as a component in Ovaphil L, a prescription medication used to aid women suffering from polycystic ovary syndrome (PCOS) to ovulate. Letrozole promotes the synthesis of hormones linked to ovulation by reducing the amount of estrogen. On the 3rd or 5th day of the period of menstruation, it is usually taken as a 2.5 mg tablet each day for five days.

Salt Consumption

Letrozole (2.5mg)

Out of stock

Category:
Guaranteed Safe Checkout

Ovaphil L is a scientifically designed ovulation induction treatment for anovulatory or abnormally ovulating women who are infertile, usually seen in Polycystic Ovary Syndrome (PCOS) or unexplained infertility. Each tablet contains Letrozole 2.5 mg 💊, a non-steroidal aromatase inhibitor and a primary cause of ovulation induction.

Letrozole exerts its effect by inhibiting the action of the aromatase enzyme, hence reducing the amount of estrogen in the body. Short-term suppression of estrogen elicits a compensatory increase in follicle-stimulating hormone (FSH) secretion from the pituitary gland. Increased levels of FSH cause stimulation and development of ovarian follicles, thus leading to ovulation 🥚.

⚙️Mechanism of Action:

  • Inhibits androgen conversion to estrogen through aromatase enzyme inhibition
  • Decreases estrogen-induced inhibition of the hypothalamic-pituitary axis
  • Promotes endogenous FSH release
  • Triggers growth of follicle in the ovary
  • Encourages timely ovulation

💡Clinical Use & Dosage:

Ovaphil L should be taken by mouth in 2.5 mg once-a-day doses for 5 successive days, best initiated on either Day 3 or Day 5 of menstruation, in accordance with individual clinician regimen. Ovulation typically follows after 5–7 days. Transvaginal ultrasound is advised to follow follicular growth.

📋Indications:

  • Anovulatory infertility, especially in PCOS
  • Irregular ovulation cycles
  • Induction of primary ovulation in resistant patients to Clomiphene Citrate
  • Unexplained infertility in certain cases

✅Advantages of Ovaphil L:

  • ✔ Increased ovulation rate among PCOS women
  • ✔ Lower multiple pregnancy rates compared to Clomiphene
  • ✔ Shorter half-life reduces undesirable endometrial effect
  • ✔ Effective in Clomiphene-resistant patients
  • ✔ Well-tolerated with minimal side effects

⚠️Safety & Precautions:

  • should be prescribed only after appropriate evaluation of cause of infertility
  • Contraindicated in liver disease and pregnancy
  • Not indicated in non-PCOS-related ovarian cysts
  • Should be taken under the supervision of an experienced gynaecologist or fertility specialist

Ovaphil L is a consistent and efficient choice for inducing ovulation, particularly in cases of PCOS-related infertility. With its mechanism of action focused on the problem, good safety profile, and evidence-based effectiveness, it is a trusted therapy for reproductive endocrinologists and gynaecologists seeking to restore spontaneous ovulation and enhance conception rates.

🌟Key Benefits of Ovaphil L (Letrozole 2.5 mg)

Ovaphil L enjoys some clinical advantages over the standard ovulation induction medication like Clomiphene Citrate💊. It is a first-line choice treatment in a wide variety of women, including those with PCOS and ovulatory dysfunction. The below points are the underlying advantages which ensure that Ovaphil L is a sure shot therapeutic drug 👩‍⚕️🌸:

  1. Higher Ovulation and Pregnancy Rates in PCOS
    Letrozole was more efficacious than Clomiphene Citrate in causing ovulation in PCOS women. Ovaphil L allows monofollicular growth 🌱, causing more regulated ovulation and greater endometrial receptiveness, which greatly optimizes opportunities for successful conception.

     

  2. Lower Risk of Multiple Pregnancies
    Unlike Clomiphene, which often generates multi-follicular development and increases twin👶👶 or higher order multiple pregnancy rates, Ovaphil L more commonly induces a single dominant follicle growth. This translates to reduced rates of multiple gestation and thus all allied maternal and fetal complications🩺.

     

  3. No Anti-Estrogenic Effect on Endometrium or Cervical Mucus
    Clomiphene Citrate has anti-estrogen effects on the cervix and the endometrium, which compromise implantation in a negative manner. Letrozole is short-acting 🕒 on aromatase and does not accumulate within the body and so enables the re-establishment of estrogen levels sooner after treatment and maintains endometrial thickness along with cervical mucus quality—the two essentials needed for implantation.

     

  4. Effective in Clomiphene-Resistant Cases
    Ovaphil L is also a good option in women who are resistant to Clomiphene Citrate therapy. Clinical studies have found that Letrozole effectively stimulates ovulation in Clomiphene-resistant patients with PCOS by avoiding the estrogen receptor pathways blocked by Clomiphene.

     

  5. Shorter Half-Life Ensures Predictable Response
    Letrozole has a shorter half-life (approximately 45 hours) than that of Clomiphene, which can stay in the body for weeks. This provides more exact cycle control and reduces residual hormonal interference in future cycles.

     

  6. Favorable Safety Profile
    Ovaphil L is well tolerated with minimal side effects. Side effects reported are usually mild and may be headache, fatigue, dizziness, or hot flushes. It is not known to have teratogenicity when administered in early follicular phase and is rapidly cleared before ovulation.

     

  7. Flexible Dosing and Monitoring
    Ovaphil L is easily integrated into various ovulation induction regimens. It may be used:
  • Used alone in timed intercourse cycles
  • Together with gonadotropins for superovulation
  • As adjuncts to intrauterine insemination (IUI) cycles
  • In ovulation induction for IVF in mild stimulation protocols

      8. Better Patient Compliance
Due to its once-daily oral dosage, short duration of therapy (typically 5 days), and lower incidence of side effects, Ovaphil L ensures better patient adherence and comfort, especially when compared to injectable alternatives.

Because of its once-daily oral administration, brief course of therapy (usually 5 days), and lesser frequency of side effects, Ovaphil L provides improved patient compliance and convenience, particularly over injectable products.

🧾In Summary, Ovaphil L provides:

  • Better ovulation outcomes
  • Better endometrial environment
  • Increased mother and fetus safety
  • Reduced treatment burden to patients
  • Efficacious handling of PCOS-related infertility

Note: This product is to be administered only under the guidance of a registered medical practitioner. Monitoring regularly and appropriate counselling are advised during treatment.

ovaphil l pcos

Ovaphil Fertility Combo – Comprehensive, Synergistic Support for Female Infertility Management

The combination of Ovaphil F, Ovaphil S, and Ovaphil L provides a multifaceted, evidence-based approach to optimize fertility results in women undergoing PCOS, anovulation, thin endometrium, or ART processes. Each product in the Ovaphil series addresses a separate but interconnected aspect of female reproductive health, which makes this trio highly effective when used in a personal fertility plan.

🔷 Ovaphil F (Myo-Inositol + D-Chiro Inositol + L-Methylfolate + Melatonin + Vitamin D3)

  • Primary Role: Metabolic & Nutritional Support
  • Establishes ovulation and hormonal balance in PCOS
  • Improves insulin sensitivity and reduces hyperandrogenism
  • Enhances oocyte Quality and Increase in Follicular Atmosphere (by Melatonin and Inositols)
  • Supports endometrial health, fetal development and early pregnancy

🔷 Ovaphil S (Sildenafil Citrate 25 mg)

  • Primary Role: Enhancing Endometrial Thickness & Uterine Blood Flow
  • Improves uterine perfusion and endometrial receptibility
  • Supports the best endometrial thickness (≥7 mm) to embryo implantation
  • Benefits in cases of thin endometrium and repetitive implantation failure
  • A letrozole cycle by adapting to the uterine environment

🔷 Ovaphil L (Letrozole 2.5 mg)

  • Primary Role: Ovulation Induction
  • Stimulates follicle development and triggers ovulation
  • First-row agent in an anovulation related to PCOS
  • Promotes monofollicular growth with minimal risk of hyperstimulation
  • High ovulation and pregnancy rate compared to Clomiphene

✅ Key Benefits of the Ovaphil Combo Therapy

1. Synergistic Ovulation Induction and Metabolic Correction

  • Ovaphil L effectively induces ovulation, especially in PCOS patients.
  • Ovaphil F is simultaneously found in underlying insulin resistance, endocrine imbalance and oxidative stress in PCOS, which improves better ovulatory response and follicular development.

2. Enhanced Endometrial Receptivity and Implantation Potential

  • When stimulating letrozole ovulation, it can sometimes limit estrogen levels affecting the endometrial lining.
  • Ovephil S compensates to increase the blood flow of the uterus, increase the endometrial thickness and create a favorable implantation environment.
  • Ovaphil F supports the endometrium via vitamin D3 and L-Methylfolate, which improves the success rate of stability.

3. Improved Oocyte Quality and Embryo Competence

  • Melatonin and inositols in ovaphil F help reduce oxidative damage in follicular fluid, which causes better quality oocytes.
  • This is especially important in the ART cycle, where the merits of the oocytes determine fetal development and implantation.

4. Comprehensive Preconception Support

  • Together, all three ends address endocrine, metabolic, vascular and nutritious factors that influence female fertility.
  • Ideal for women preparing for natural conception, IUI or IVF protocols, this combo enhances the entire reproductive axis – from ovulation to planting.

5. Reduced Risk of Treatment Failure

  • Monotherapy is often low in complex cases such as PCOS or recurrent implantation failure.
  • The ovaphil combination reduces the possibility of anovulatory cycles, thin endometrium, or poor embryo quality, causing high cycle success rates.

🧬 Precision Fertility Care with the Ovaphil Combo

By integrating Ovaphil L (Letrozole) for reliable ovulation, Ovaphil S (Sildenafil) for endometrial optimization, and Ovaphil F (Nutraceutical support) for metabolic, hormonal, and cellular health—this combination offers a holistic and personalized approach to modern fertility management.

This evidence-based trio supports better clinical outcomes, higher pregnancy rates, and improved patient satisfaction in women dealing with infertility, particularly those with PCOS, poor endometrial response, or suboptimal oocyte quality.

✅ Ovaphil Fertility Combo – Synergistic Benefits at a Glance

Product

Composition

Primary Action

Key Benefits

Ideal For

Ovaphil L

Letrozole 2.5 mg

Ovulation Induction

– Triggers development and release of mature egg

– Effective in PCOS-related anovulation

– Better endometrial profile vs. Clomiphene

– Women with anovulation

– PCOS

– Ovulation induction cycles

Ovaphil S

Sildenafil Citrate 25 mg

Enhances Endometrial Thickness & Uterine Perfusion

– Improves uterine blood flow

– Increases endometrial thickness (≥7 mm)

– Enhances implantation success

– Thin endometrium

– Recurrent implantation failure

– ART/IUI/IVF cycles

Ovaphil F

Myo-Inositol 1 g

D-Chiro Inositol 25 mg

L-Methylfolate 500 mcg

Melatonin 1.5 mg

Vitamin D3 1000 IU

Metabolic & Nutritional Reproductive Support

– Restores ovulation in PCOS

– Improves oocyte quality

– Enhances insulin sensitivity

– Supports endometrium and embryo development

– PCOS

– Irregular ovulation

– Poor oocyte quality

– Preconception support

🔄 Combined Benefits of Ovaphil L + S + F

Combined Action

Synergistic Outcome

Letrozole-induced ovulation + Inositol-based metabolic correction

Higher ovulatory response in PCOS, improved follicular development

Sildenafil-enhanced uterine perfusion + Vitamin D & folate support

Improved endometrial thickness, receptivity, and implantation potential

Melatonin + Inositols + Letrozole

Better oocyte quality, lower oxidative stress, enhanced embryo competence

Full reproductive axis support: ovulation → endometrium → implantation

Increased conception success, especially in IUI/IVF and PCOS-related infertility

The Ovaphil Combo provides a comprehensive, multi-targeted fertility solution, improving outcomes across all stages of the conception process – from ovulation and oocyte quality to endometrial health and implantation. Ideal for PCOS, anovulation, ART cycles, and preconception care.

FAQ's

When is the best time to take Ovaphil L during a cycle?
As directed, it is typically taken on days 2–6 or 3–7 of the menstrual cycle.

Will Ovaphil L have an impact on subsequent menstrual cycles?
By encouraging ovulation, it might eventually aid in cycle regulation.

Is it safe to use Ovaphil L without a doctor’s supervision?
No, it should only be taken as prescribed by a doctor.

Does Ovaphil L have any adverse effects?
Hot flashes, exhaustion, lightheadedness, or nausea are possible adverse effects.

Does Ovaphil L increase the likelihood of getting pregnant?
Yes, it raises the chance of conception by causing ovulation.

Reviews

There are no reviews yet.

Be the first to review “Ovaphil L”

Your email address will not be published. Required fields are marked *

Shopping Cart